| Noriday 350 micrograms Tablets PA0822/131/001 |
Norethisterone |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Nyvepria 6 mg solution for injection EU/1/20/1486/001 |
Pegfilgrastim |
Pfizer Europe MA EEIG |
— |
| Octreotide 100 micrograms/1 ml solution for injection PA0822/218/002 |
Octreotide acetate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Octreotide 50 micrograms/1 ml solution for injection PA0822/218/001 |
Octreotide acetate |
Pfizer Healthcare Ireland Unlimited Company |
Not marketed |
| Octreotide 500 micrograms/1 ml solution for injection PA0822/218/004 |
Octreotide acetate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Ovranette 150 micrograms/30 micrograms coated tablets PA0822/094/001 |
Ethinyloestradiol, Levonorgestrel |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Oxbryta EU/1/21/1622/001 |
Voxelotor |
Pfizer Europe MA EEIG |
— |
| Paxlovid 150 mg + 100 mg Film-coated tablet EU/1/22/1625/001 |
PF-07321332 |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 1,000 mg powder for concentrate for solution for infusion EU/1/15/1057/003 |
Pemetrexed disodium |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 1,000 mg powder for concentrate for solution for infusion EU/1/17/1183/003 |
Pemetrexed ditromethamine |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 100 mg powder for concentrate for solution for infusion EU/1/15/1057/001 |
Pemetrexed disodium |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 100 mg powder for concentrate for solution for infusion EU/1/17/1183/001 |
Pemetrexed ditromethamine |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 25 mg/ml concentrate for solution for infusion EU/1/15/1057/004-006 |
Pemetrexed Disodium Hemipentahydrate, Pemetrexed |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 500 mg powder for concentrate for solution for infusion EU/1/15/1057/002 |
Pemetrexed disodium |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 500 mg powder for concentrate for solution for infusion EU/1/17/1183/002 |
Pemetrexed ditromethamine |
Pfizer Europe MA EEIG |
— |
| Premarin 0.625 mg Prolonged-release tablets PA0822/095/002 |
Conjugated estrogens |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Premarin 1.25 mg Prolonged-release tablets PA0822/095/003 |
Conjugated estrogens |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Prevenar 13 suspension for injection pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) EU/1/09/590/1-6 |
Polysaccharide serotype 14, Polysaccharide serotype 23f, Polysaccharide serotype 19f, Polysaccharide serotype 9v, Polysaccharide serotype 3 |
Pfizer Europe MA EEIG |
— |
| Prevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed) EU/1/21/1612/001-006 |
Pneumococcal polysaccharide serotype 1, Pneumococcal Polysaccharide Serotype 3, Pneumococcal polysaccharide serotype 4, Pneumococcal polysaccharide serotype 5, Pneumococcal Polysaccharide Serotype 6A |
Pfizer Europe MA EEIG |
— |
| Pro-Epanutin 75 mg/ml concentrate for solution for infusion/solution for injection PA0822/019/001 |
Fosphenytoin sodium |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Prostin E2 1 mg Vaginal Gel PA0822/178/001 |
Dinoprostone |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Prostin E2 1mg/ml Concentrate for solution for infusion PA0822/133/003 |
Dinoprostone |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Prostin E2 2 mg Vaginal Gel PA0822/178/002 |
Dinoprostone |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Provera 10 mg tablets PA0822/134/003 |
Medroxyprogesterone acetate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Rapamune EU/1/01/171/14 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 0.5 mg Coated tablet EU/1/01/171/013-014 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 1 mg Coated tablet EU/1/01/171/007 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 1 mg Coated tablet EU/1/01/171/008 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 1 mg/ml Oral solution EU/1/01/171/001 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 2 mg Coated tablet EU/1/01/171/009-010 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 1000 IU powder and solvent for solution for injection EU/1/99/103/003 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 1000 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/007 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 2000 IU powder and solvent for solution for injection EU/1/99/103/004 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 2000 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/008 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 250 IU powder and solvent for solution for injection EU/1/99/103/001 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 3000 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/005 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 500 IU powder and solvent for solution for injection EU/1/99/103/002 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 500 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/006 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| Retacrit EU/1/07/431/17-19 |
Epoetin zeta |
Pfizer Europe MA EEIG |
— |
| Retacrit EU/1/07/431/7-16 |
Epoetin zeta |
Pfizer Europe MA EEIG |
— |
| Retacrit 1000 IU/0.3 ml Solution for injection EU/1/07/431/1-6 |
Epoetin zeta |
Pfizer Europe MA EEIG |
— |
| Ruxience 100 mg concentrate for solution for infusion EU/1/20/1431/001 |
Rituximab |
Pfizer Europe MA EEIG |
— |
| Ruxience 500 mg concentrate for solution for infusion EU/1/20/1431/002 |
Rituximab |
Pfizer Europe MA EEIG |
— |
| Salazopyrin® 500 mg Tablets PA0822/196/002 |
Sulfasalazine |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Salazopyrin® EN Tabs 500 mg Gastro-resistant tablets PA0822/196/001 |
Sulfasalazine |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Solu-Cortef Powder for Solution for Injection or Infusion 100mg PA0822/137/001 |
Hydrocortisone sodium phosphate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Solu-Medrone powder and solvent for solution for injection or concentrate for solution for infusion 1000 mg/vial PA0822/136/004 |
Methylprednisolone |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Solu-Medrone powder and solvent for solution for injection or concentrate for solution for infusion 125 mg/vial PA0822/136/002 |
Methylprednisolone |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Solu-Medrone powder and solvent for solution for injection or concentrate for solution for infusion 40 mg/vial PA0822/136/001 |
Methylprednisolone |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Solu-Medrone powder and solvent for solution for injection or concentrate for solution for infusion 500 mg/vial PA0822/136/003 |
Methylprednisolone |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |